AI assistant
NEOGENOMICS INC — Director's Dealing 2022
Oct 28, 2022
32227_dirs_2022-10-28_4920900e-ec14-41a6-89c5-59b8d1360547.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-10-18
Reporting Person: Olivo Alicia C (General Counsel)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 40999 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $19.12 | 2026-09-30 | Common Stock (1046.0) | Direct | |
| Stock Option (Right to Buy) | $27.34 | 2027-05-01 | Common Stock (1024.0) | Direct | |
| Stock Option (Right to Buy) | $48.99 | 2028-05-01 | Common Stock (516.0) | Direct | |
| Stock Option (Right to Buy) | $46.1 | 2028-08-01 | Common Stock (1117.0) | Direct | |
| Stock Option (Right to Buy) | $9.45 | 2029-05-01 | Common Stock (22222.0) | Direct | |
| Stock Option (Right to Buy) | $10.05 | 2029-09-01 | Common Stock (55332.0) | Direct |
Footnotes
F1: On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F2: On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F3: On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F4: On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F5: On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F6: On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.